UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

Annals of oncology, 2017-04, Vol.28 (4), p.769-776

2017

Volltextzugriff (PDF)

Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer

Annals of oncology, 2013-05, Vol.24 (5), p.1231-1238

2013

Volltextzugriff (PDF)

Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy

Oncogene, 2006-02, Vol.25 (7), p.981-989

2006

Volltextzugriff (PDF)

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2016-08, Vol.51 (8), p.1082-1086

2016

Volltextzugriff (PDF)

Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients

Annals of oncology, 2013-03, Vol.24 (3), p.625-632

2013

Volltextzugriff (PDF)

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines

Oncogene, 2007-11, Vol.26 (50), p.7163-7169

2007

Volltextzugriff (PDF)

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer

Oncogene, 2007-01, Vol.26 (2), p.298-307

2007

Volltextzugriff (PDF)

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study

BMC cancer, 2015-10, Vol.15 (1), p.697, Article 697

2015

Volltextzugriff (PDF)

Recent Trends in Epidemiology of Brain Metastases: An Overview

Anticancer research, 2012-11, Vol.32 (11), p.4655-4662

2012

Volltextzugriff (PDF)

Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudes

European journal of cancer care, 2012-03, Vol.21 (2), p.242-250

2012

Volltextzugriff (PDF)

Participants' uptake of clinical trial results: a randomised experiment

British journal of cancer, 2010-03, Vol.102 (7), p.1081-1084

2010

Volltextzugriff (PDF)

Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic study

Annals of oncology, 2010-07, Vol.21 (7), p.1448-1454

2010

Volltextzugriff (PDF)

Inflammatory breast cancer in Tunisia in the era of multimodality therapy

Annals of oncology, 2008-03, Vol.19 (3), p.473-480

2008

Volltextzugriff (PDF)

Breast Cancer Patients’ Views on the Use of Genomic Testing to Guide Decisions about Their Postoperative Chemotherapy

Public health genomics, 2013-01, Vol.16 (3), p.110-117

2013

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients

Bone marrow transplantation (Basingstoke), 2002-07, Vol.30 (2), p.95-102

2002

Volltextzugriff (PDF)

High-dose Alkylating Agents with Autologous Hematopoietic Stem Cell Support and Trastuzumab in ERBB2 Overexpressing Metastatic Breast Cancer: A Feasibility Study

Anticancer research, 2005-01, Vol.25 (1B), p.663-667

2005

Volltextzugriff (PDF)

Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis

The Journal of pathology, 1998-02, Vol.184 (2), p.130-135

1998

Volltextzugriff (PDF)

Patient participation in medical decision-making: A French study in adjuvant radio-chemotherapy for early breast cancer

Annals of oncology, 2000-01, Vol.11 (1), p.39-45

2000

Volltextzugriff (PDF)

Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care

British journal of cancer, 1997, Vol.76 (12), p.1640-1645

1997

Volltextzugriff (PDF)

Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles

Supportive care in cancer, 2002-04, Vol.10 (3), p.222-230

2002

Volltextzugriff (PDF)

Identification and validation of an ERBB2 gene expression signature in breast cancers

Oncogene, 2004-04, Vol.23 (14), p.2564-2575

2004

Volltextzugriff (PDF)

Altérations moléculaires des cancers du sein : applications cliniques et nouveaux outils d'analyse

La revue de medecine interne, 2005-06, Vol.26 (6), p.470-478

2005

Volltextzugriff (PDF)

High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer : pathologic response and outcome

Bone marrow transplantation (Basingstoke), 1998-02, Vol.21 (3), p.249-254

1998

Volltextzugriff (PDF)

Occult tumor cell contamination in patients with stage II III breast cancer receiving sequential high-dose chemotherapy

Bone marrow transplantation (Basingstoke), 2003-12, Vol.32 (11), p.1059-1064

2003

Volltextzugriff (PDF)

Profils d'expression génique sur puces à ADN en cancérologie mammaire : principes et applications pronostiques

Pathologie biologie (Paris), 2006-02, Vol.54 (1), p.49-54

2006

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

ThemaBreast Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(54)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer

Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study

Recent Trends in Epidemiology of Brain Metastases: An Overview

Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudes

Participants' uptake of clinical trial results: a randomised experiment

Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic study

Inflammatory breast cancer in Tunisia in the era of multimodality therapy

Breast Cancer Patients’ Views on the Use of Genomic Testing to Guide Decisions about Their Postoperative Chemotherapy

Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients

High-dose Alkylating Agents with Autologous Hematopoietic Stem Cell Support and Trastuzumab in ERBB2 Overexpressing Metastatic Breast Cancer: A Feasibility Study

Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis

Patient participation in medical decision-making: A French study in adjuvant radio-chemotherapy for early breast cancer

Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care

Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles

Identification and validation of an ERBB2 gene expression signature in breast cancers

Altérations moléculaires des cancers du sein : applications cliniques et nouveaux outils d'analyse

High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer : pathologic response and outcome

Occult tumor cell contamination in patients with stage II III breast cancer receiving sequential high-dose chemotherapy

Profils d'expression génique sur puces à ADN en cancérologie mammaire : principes et applications pronostiques

Aktive Filter

Suchergebnisse filtern